View Archived Issues

Aug. 22, 2019

Vol. 18
No. 162


Senator Presses FDA on Progress in Addressing Drug Shortages

U.S. Sen. Gary Peters (D-Mich.) sent a letter Wednesday to acting FDA Commissioner Ned Sharpless asking what the agency is doing to curb drug shortages. Read More

White House Highlights ‘Red Flags’ for Illicit Fentanyl

The White House on Wednesday highlighted the administration’s ongoing efforts to rein in illegal fentanyl trafficking and unveiled a series of advisories to help businesses identify “red flags.” Read More

Aspen Pharma Agrees to Pay Almost $10 Million to Settle UK Anti-Competition Probe

In a first for the UK’s Competition and Markets Authority (CMA), Aspen Pharma agreed to pay the National Health Service £8 million ($9.7 million) to settle anti-competition charges involving fludrocortisone acetate — an oral corticosteroid used to treat Addison’s disease and for other conditions. Read More

Florida Drugmaker Warned for Repeat Violations

The FDA hit TG United’s drug manufacturing facility north of Tampa, Florida with a warning letter for repeat water system and cleaning failures found during a lengthy inspection. Read More